Published in Ophthalmology on September 01, 1993
Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study. Cornea (2013) 0.99
Doxycycline-a role in ocular surface repair. Br J Ophthalmol (2004) 0.98
The effect of doxycycline temperature-sensitive hydrogel on inhibiting the corneal neovascularization induced by BFGF in rats. Graefes Arch Clin Exp Ophthalmol (2010) 0.87
Tetracycline treatment of phlyctenulosis. Ophthalmology (1994) 0.75
Oral azithromycin combined with topical anti-inflammatory agents in the treatment of blepharokeratoconjunctivitis in children. J AAPOS (2013) 0.75
Phlyctenular keratoconjunctivitis among children in the tertiary eye hospital of Kathmandu, Nepal. Oman J Ophthalmol (2016) 0.75
alpha-Synuclein locus triplication causes Parkinson's disease. Science (2003) 20.20
A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg (2001) 11.58
Mapping striate and extrastriate visual areas in human cerebral cortex. Proc Natl Acad Sci U S A (1996) 4.69
Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology (1998) 3.79
Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci (2001) 3.72
Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Ophthalmol (1996) 3.50
Nosocomial endophthalmitis survey. Current incidence of infection after intraocular surgery. Ophthalmology (1991) 3.38
Viscocanalostomy for open-angle glaucoma in black African patients. J Cataract Refract Surg (1999) 3.32
Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen. Proc Natl Acad Sci U S A (1988) 3.25
The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea (1998) 2.86
Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J Psychoactive Drugs (2000) 2.82
Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology (2000) 2.70
A 'pseudo-AIDS' syndrome following from fear of AIDS. Br J Psychiatry (1985) 2.69
IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol (2009) 2.65
Effects of laser in situ keratomileusis on tear production, clearance, and the ocular surface. Ophthalmology (2001) 2.62
Psychological support and counselling for patients with acquired immune deficiency syndrome (AIDS). Genitourin Med (1985) 2.59
HIV infection: increase in public awareness and anxiety. Br Med J (Clin Res Ed) (1987) 2.52
HTLV-III: should testing ever be routine? Br Med J (Clin Res Ed) (1986) 2.51
Epidural versus continuous transversus abdominis plane catheter technique for postoperative analgesia after abdominal surgery. Anaesth Intensive Care (2013) 2.51
Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology. Neurology (2012) 2.50
The changing spectrum of fungal keratitis in south Florida. Ophthalmology (1994) 2.29
Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann Neurol (1999) 2.28
Building-associated pulmonary disease from exposure to Stachybotrys chartarum and Aspergillus versicolor. J Occup Environ Med (1998) 2.15
Delayed-onset pseudophakic endophthalmitis. Am J Ophthalmol (1991) 2.11
Occupational strain and the incidence of coronary heart disease. Am J Epidemiol (1989) 2.10
Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators. Circulation (1995) 2.07
Breeding difficulties. Vet Rec (2001) 2.07
Functional magnetic resonance imaging (FMRI) of the human brain. J Neurosci Methods (1994) 2.02
Symptoms of schizophrenia. Methods, meanings, and mechanisms. Arch Gen Psychiatry (1995) 2.00
Current activities at the Centers for Disease Control and Prevention's National Diabetes Laboratory. Diabetes Technol Ther (1999) 1.95
Why AIDS is not a notifiable disease. S Afr Med J (1992) 1.92
Antibody to human T-lymphotropic virus type 1 in West-Indian-born UK residents with spastic paraparesis. Lancet (1987) 1.92
Dimethylthetin can substitute for glycine betaine as an osmoprotectant molecule for Escherichia coli. J Bacteriol (1987) 1.91
The importance of radiating leg pain in assessing health outcomes among patients with low back pain. Results from the Veterans Health Study. Spine (Phila Pa 1976) (1998) 1.89
Topical anesthetic abuse. Ophthalmology (1990) 1.86
Paracentral rheumatoid corneal ulceration. Clinical features and cyclosporine therapy. Ophthalmology (1992) 1.83
Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia. Am J Psychiatry (2000) 1.83
Postoperative Propionibacterium endophthalmitis. Treatment strategies and long-term results. Ophthalmology (1993) 1.79
Eight-year follow-up study of brain atrophy in patients with MS. Neurology (2002) 1.78
Chronic and recovered cases of sheep-associated malignant catarrhal fever in cattle. Vet Rec (1997) 1.78
Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea. Invest Ophthalmol Vis Sci (1999) 1.74
Endophthalmitis caused by gram-negative organisms. Arch Ophthalmol (1992) 1.72
Is variant angina the coronary manifestation of a generalized vasospastic disorder? N Engl J Med (1981) 1.71
Detection of herpesvirus DNA in vitreous and aqueous specimens by the polymerase chain reaction. Arch Ophthalmol (1991) 1.70
Significance of C-terminal cysteine modifications to the biological activity of the Saccharomyces cerevisiae a-factor mating pheromone. Mol Cell Biol (1991) 1.70
Regulation of MMP-9 production by human corneal epithelial cells. Exp Eye Res (2001) 1.69
Effects of ENU dosage on mouse strains. Mamm Genome (2000) 1.69
Ectopic ACTH, prostatic oat cell carcinoma, and marked hypernatremia. Cancer (1977) 1.69
Constitutional hepatic dysfunction (CHD; Gilbert's disease); a review with special reference to a characteristic increase and prolongation of the hyperbilirubinemic response to nicotinic acid. Medicine (Baltimore) (1972) 1.68
Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment. Clin Exp Immunol (2008) 1.68
Depression in grandparents raising grandchildren: results of a national longitudinal study. Arch Fam Med (1997) 1.67
Measles vaccination and neurological events. Lancet (1997) 1.66
The feasibility of a web-based surveillance system to collect health risk behavior data from college students. Health Educ Behav (2001) 1.66
Evaluation of a nurse specialist anticoagulant service. Clin Lab Haematol (1997) 1.66
Antitumor activity of sorafenib in FLT3-driven leukemic cells. Leukemia (2007) 1.65
Gastroduodenitis. A broader concept of peptic ulcer disease. Dig Dis Sci (1980) 1.59
Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis. Lancet (1994) 1.59
Corneal biopsy in the management of progressive microbial keratitis. Am J Ophthalmol (2000) 1.56
Treatment strategies and visual acuity outcomes in chronic postoperative Propionibacterium acnes endophthalmitis. Ophthalmology (1999) 1.55
Evolution of homeobox genes: Q50 Paired-like genes founded the Paired class. Dev Genes Evol (1999) 1.55
Neutralizing antibodies during treatment of secondary progressive MS with interferon beta-1b. Neurology (2003) 1.54
Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol (2000) 1.54
Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int (2000) 1.52
Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients. Proc Natl Acad Sci U S A (1986) 1.51
Periocular atypical mycobacterial infections. Ophthalmology (1999) 1.50
Conjunctival cytologic features of primary Sjögren's syndrome. Ophthalmology (1990) 1.49
Regulation of the synthesis of adenylate cyclase in Escherichia coli by the cAMP -- cAMP receptor protein complex. Mol Gen Genet (1981) 1.49
Evaluation of corneal thickness and topography in normal eyes using the Orbscan corneal topography system. Br J Ophthalmol (1999) 1.46
Endogenous endophthalmitis caused by Histoplasma capsulatum var. capsulatum: a case report and literature review. Ophthalmology (2000) 1.46
Suppression of interleukin 1alpha and interleukin 1beta in human limbal epithelial cells cultured on the amniotic membrane stromal matrix. Br J Ophthalmol (2001) 1.46
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria. J Neurol Neurosurg Psychiatry (1997) 1.44
Cholinergic stimulation of lactoferrin and epidermal growth factor secretion by the human lacrimal gland. Cornea (1996) 1.44
Integrated backscatter for quantification of left atrial spontaneous echo contrast. J Am Coll Cardiol (1996) 1.43
Sequential injection of 3% sodium tetradecyl sulfate and 20% sodium chloride in the treatment of refractory varicosity of the greater saphenous vein. J Dermatol Surg Oncol (1994) 1.43
Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis. Neurology (2005) 1.43
Effectiveness of glucose monitoring systems modified for the visually impaired. Diabetes Care (1993) 1.42
The Medication Reduction Project: combating polypharmacy in South Dakota elders through community-based interventions. S D J Med (1996) 1.41
Corneal toxicity with an antibiotic/steroid-soaked collagen shield. Arch Ophthalmol (1992) 1.40
Scleral buckle removal following retinal reattachment surgery: clinical and microbiologic aspects. Ophthalmic Surg (1993) 1.39
Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids. Am J Ophthalmol (2001) 1.39
Monoclonal antibody studies of mammalian epithelial keratins: a review. Ann N Y Acad Sci (1985) 1.39
Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms. Ophthalmology (1999) 1.38
Publishing and the Internet. Can J Anaesth (1995) 1.38
Microbial keratitis in children. Ophthalmology (1998) 1.36
Neutrophil adherence to isolated adult cardiac myocytes. Induction by cardiac lymph collected during ischemia and reperfusion. J Clin Invest (1992) 1.36
A novel membrane receptor with high affinity for lysosphingomyelin and sphingosine 1-phosphate in atrial myocytes. EMBO J (1996) 1.34
The effects of age, gender, and fluid dynamics on the concentration of tear film epidermal growth factor. Cornea (1997) 1.33
Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome. Ophthalmology (1999) 1.33
A longitudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change. Arch Gen Psychiatry (1995) 1.32
Indoor air quality and health: validity and determinants of reported home dampness and moulds. Int J Epidemiol (1997) 1.32
Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia. J Leukoc Biol (2000) 1.32
Elastase-mediated fibrinogenolysis by chemoattractant-stimulated neutrophils occurs in the presence of physiologic concentrations of antiproteinases. J Exp Med (1987) 1.32
Evaluation of a computer-directed pneumatic-tube system for pneumatic transport of blood specimens. Am J Clin Pathol (1978) 1.32
Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein. Mol Endocrinol (1997) 1.31
Quality of life in multiple sclerosis. Comparison with inflammatory bowel disease and rheumatoid arthritis. Arch Neurol (1992) 1.31
Alterations of ocular surface gene expression in Sjögren's syndrome. Adv Exp Med Biol (1998) 1.30